Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Yazar: Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Baskı/Yayın Bilgisi 2014

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

Yazar: Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Baskı/Yayın Bilgisi 2009

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

Yazar: Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K
Yayımlandı Br J Cancer (2016)